Abstract
Obesity, like all complex diseases, is believed to have both a genetic and an environmental component. Data supporting an important role for environment in obesity come from the recent rise in the incidence of obesity over the past few decades. This review will present a new hypothesis for the etiology of obesity: the obesogen hypothesis. This emerging hypothesis states that susceptibility to develop obesity is due to exposure to environmental chemicals during development in utero and the first few years of life. Proof of principle for this hypothesis comes from smoking during pregnancy, which results in increased weight gain in children. There are examples using animal models for developmental exposures to chemicals with estrogenic activity [diethylstilbestrol, genistein (soy phytoestrogen) and bisphenol A (polycarbonate), tributyltin (a component of PVC)] and several pesticides resulting in increased weight gain later in life. An important aspect of the obesogen hypothesis is that obesity due to environmental exposure can be prevented by reducing exposure. Thus, this new hypothesis changes the focus from treatment to prevention of obesity.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
NHANES Data on the Prevalence of Overweight Among Children and Adolescents: United States. 2003–2006. CDC National Center for Health Statistics, Health E-Stat.
Kim J, Peterson KE, Scanlon KS, Fitzmaurice GM, Must A, Oken E, Rifas-Shiman SL, Rich-Edwards JW, Gillman MW. Trends in overweight from 1980 through 2001 among preschool-aged children enrolled in a health maintenance organization. Obesity. 2006;14:1107–2.
Loos RJF. Recent progress in the genetics of common obesity. Br J Clin Pharm. 2009;68:811–29.
Hill AJ. Does dieting make you fat? Br J Nutr. 2004;92:S15–8.
Wadhwa PD, Buss C, Entringer S, Swanson JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009;27:358–68.
Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007;261:412–7.
Gluckman PD, Hanson MA, Pinal C. The developmental origins of adult disease. Matern Child Nutr. 2005;1(3):130–41.
Gluckman PD, Hanson MA, Beedle AS, Raubenheimer D. Fetal and neonatal pathways to obesity. Front Horm Res. 2008;36:61–72.
Fall C. Maternal nutrition: effects on health in the next generation. Indian J Med Res. 2009;130:593–9.
Wright CS, Rifas-Shiman SL, Rich-Edwards JW, Taveras EM, Gillman MW, Oken E. Intrauterine exposure to gestational diabetes, childhood adiposity, and blood pressure. Am J Hypertens. 2009;22:215–20.
Oken E, Gillman MW. Fetal origins of obesity. Obes Res. 2003;11:496–506.
Stettler N, Stallings VA, Troxel AB, Zhao J, Schinnar R, Nelson SE, Ziegler EE, Strom SJ. Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation. 2005;111:1897–903.
Stettler N. Nature and strength of epidemiological evidence for origins of childhood and adulthood obesity in the first year of life. Int J Obes. 2007;31:1035–43.
Newbold RR, Heindel JJ. Developmental exposures and implications for early and latent disease. In: Woodruff TJ, Janssen SJ, Guillette LJ and Giudice LC editors. Environmental impacts on reproductive health and fertility. Cambridge University Press; New York, NY 2010. pp. 92–102.
Newbold RR, Heindel JJ. Developmental origins of health and disease: the importance of environmental exposures. In: Newnham JP and Ross MD editors. Early life origins of human health and disease. Karger Press, Basel, Switzerland 2009. pp. 41–50.
Grandjean P. PPTOX prenatal programming and toxicity. Basic Clin Pharmacol Toxicol. 2008;102(2):1–273.
Grun F, Blumberg B. Minireview: the case for obesogens. Mol Endocrinol. 2009;23:1127–34.
Heindel JJ, vom Saal FS. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol. 2009;304:90–6.
Newbold R, Padilla-Banks E, Jefferson W. Molecular and cellular endocrinology. Mol Cell Endocrinol. 2009;304:84–9.
Edwards JR, Prozialeck WC. Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol. 2009;238:289–93.
Longnecker MP, Daniels JL. Environmental contaminants as etiologic factors for diabetes. Environ Health Perspect. 2001;109 Suppl 6:871–6.
Tseng CH. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol Appl Pharmacol. 2004;197:67–83.
Schwartz GG, Il’yasova D, Ivanova A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care. 2003;26:468–70.
Uemura H, Arisawa K, Hiyoshi M, Kitayama A, Takami H, Sawachika F, Dakeshita S, Nii K, Satoh H, Sumiyoshi Y, Morinaga K, Kodama K, Suzuki T, Nagai M, Suzuki T. Prevalence of metabolic syndrome associated with body burden levels of dioxin and related compounds among Japan’s general population. Environ Health Perspect. 2009;117:568–73.
Pozharny Y, Lambertini L, Clunie G, Ferrara L, Lee M-J. Epigenetics in women’s health care. Mt Sinai J Med. 2010;77:225–35.
Bollati V, Baccarelli A. Environmental epigenetics. Heredity. 2010;105(1):105–12. Feb 24 2010; [Epub ahead of print].
Heijmans BT, Tobi EW, Lumey LH, Slagboom PE. The epigenome, archive of the prenatal environment. Epigenetics. 2009;4:1–6.
van der Meulen Jan. Commentary: maternal smoking during pregnancy and obesity in the offspring. Int J Epidemiol. 2002;31:420–1.
Oken E, Levitan E, Gillman M. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes. 2008;32:201–10.
Toschke AM, Montgomery SM, Pfeiffer U, von Kries R. Early intrauterine exposure to tobacco-inhaled products and obesity. Am J Epidemiol. 2003;158:1068–74.
Verhulst SL, Nelen V, Hond ED, Kiippen G, Beunckens C, Vael C, Schoeters G, Desager K. Intrauterine exposure to environmental pollutants and body mass index during the first 3 years of life. Environ Health Perspect. 2009;117:122–6.
Smink A, Ribas-Fito N, Garcia R, Torrent M, Mendez MA, Grimalt JO, Sunyer J. Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatr. 2008;97:1465–9.
Chen A, Pennell M, Klebanoff M, et al. Maternal smoking during pregnancy in relation to child overweight: follow-up to age 8 years. Int J Epidemiol. 2006;35:121–30.
Power C, Jefferis B. Fetal environment and subsequent obesity: a study of material smoking. Int J Epidemiol. 2002;31:413–9.
Syme C, Abrahamowicz M, Mahboubi A, et al. Prenatal exposure to maternal cigarette smoking and accumulation of intra-abdominal fat during adolescence. Obesity. 2009;18(5):1021–5.
Sharma AJ, Cogswell ME, Li R. Dose-response associations between maternal smoking during pregnancy and subsequent childhood obesity: effect modification by maternal race/ethnicity in a low-income US cohort. Am J Epidemiol. 2008;168(9):995–1007.
Huang JS, Lee TA, Lu MC. Prenatal programming of childhood overweight and obesity. Matern Child Health. 2007;11:461–73.
Hertz-Picciotto I, Charles MJ, James RA, Keller JA, Willman E, Teplin S. In utero polychlorinated biphenyl exposures in relation to fetal and early childhood growth. Epidemiology. 2005;16:648–56.
Perez-Pozo SE, Schold J, Nakagawa T, Sanchez-Lozada LG, Johnson RJ, Lillo JL. Excessive fructose intake induces the features of metabolic syndrome in health adult men: role of uric acid in the hypertensive response. Int J Obes. 2010;34:454–61.
Bantle JP. Dietary fructose and metabolic syndrome and diabetes. J Nutr. 2009;139:1263S–8S.
Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010;7(5):251–64 [April 6 ahead of print].
Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes. 2004;53:1253–60.
Dawson R. Developmental and sex-specific effects of low dose neonatal monosodium glutamate administration on mediobasal hypothalamic chemistry. Neuroendocrinology. 1986;42:158–66.
He K, Daviglus ML, Dyer AR, Van Horn L, Garside D, Zhu L, Guo D, Wu Y, Shou B, Stamler J. INTERMAP Cooperative Research Group Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP study. Obesity. 2008;16:1875–80.
Desvergne B, Feige JN, Casals-Sasas C. PPAR-mediated activity of phthalates: a link to the obesity epidemic?. Mol Cell Endo. 2009;304:43–8.
Hatch E, Nelson J, Stahlhut R, et al. Association of endocrine disruptors and obesity: perspectives from epidemiological studies. Int J Andrology. Jan 22 2010;33(2):324–32.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Heindel, J.J. (2011). The Obesogen Hypothesis of Obesity: Overview and Human Evidence. In: Lustig, R. (eds) Obesity Before Birth. Endocrine Updates, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7034-3_17
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7034-3_17
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-7033-6
Online ISBN: 978-1-4419-7034-3
eBook Packages: MedicineMedicine (R0)